At a glance
ClinicalIndex Comparison RecordN/ACompleted· 294 enrolled
Drug / intervention
Therapy ON +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
EMPOWER Clinical Trial: Vagal Blocking for Obesity Control
In Brief
A clinical study evaluating Therapy ON and Therapy OFF for Obesity. Completed, enrolled 294 participants across 15 sites in 2 countries.
Detailed Summary
This is a randomized multi-center study being done to measure the ability of a new medical device, Maestro System, to safely reduce body weight over five years in people who are considered obese.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesAustralia, United States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedAug 2007
Primary CompletionOct 2009
Study CompletionMay 2018
TodayJul 2026
First PostedAug 27, 2007
Enrollment StartAug 1, 2007
Primary CompletionOct 1, 2009
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 18.8 years ago
Interventions
Therapy ONdevice
Intermittent, programmable, intra-abdominal vagal blocking device that delivers therapy (Therapy ON)
Therapy OFFdevice
Active intra-abdominal placebo device that delivers no therapy (Therapy OFF)